Avodart Générique est utilisé pour traiter les symptômes de l'hyperplasie bénigne de la prostate ou HBP. Il aide également à réduire le risque de bloquage urinaire et le risque d'avoir à recourir à une chirurgie de la prostate.
Dutasteride May Decrease Risk of BPH Clinical Progression - Renal and Urology News
Dutasteride May Decrease Risk of BPH Clinical ProgressionRenal and Urology NewsATLANTA—Men with enlarged prostates may be able to decrease the likelihood of clinical progression of their condition by taking dutasteride, according to study findings presented at the American Urological Association 2012 annual meeting.
BPH Symptoms Can Be Improved with New Thermobalancing Therapy Without ... - DigitalJournal.com (press release)
PR WebBPH Symptoms Can Be Improved with New Thermobalancing Therapy Without .
Cholesterol-lowering drugs may slow prostate growth - Medical Xpress
Cholesterol-lowering drugs may slow prostate growthMedical XpressMuller and colleagues used data gathered for an unrelated, large trial originally testing whether a drug called dutasteride could help reduce the risk of prostate cancer.
AUA 2012 - Evidence suggests statin use may slow prostate growth - Press Release - UroToday
AUA 2012 - Evidence suggests statin use may slow prostate growth - Press ReleaseUroTodayResearchers at several leading institutions in the United States and Canada, including Duke University Medical Center, assessed this hypothesis using data from the REduction by DUtasteride of Prostate Cancer Events (REDUCE) trial.
Some Cholesterol Drugs May Slow Prostate Growth - WebMD
Some Cholesterol Drugs May Slow Prostate GrowthWebMDMuller and his team used data from a large study of the drug Avodart (dutasteride), which is prescribed to treat benign prostate hyperplasia (BPH), a noncancerous enlargement of the prostate.